IMRIC’S Yuval Dor Recipient Of Merck $1 Million Grant For Multiple Sclerosis Innovation
Merck, a leading science and technology company, today announced recipients of the fourth annual Grant for Multiple Sclerosis Innovation (GMSI) during a symposium at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in…